Latest statistics and disclosures from Gainplan's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, IWF, SCHB, AGG, LQD, and represent 80.14% of Gainplan's stock portfolio.
- Added to shares of these 10 stocks: SPY (+$39.37M), IWF (+$38.05M), AGG (+$25.16M), LQD (+$14.19M), Vanguard S&p 500 Etf idx fd, Mortgage Reit Index real, BND, GWL, VO, Karuna Therapeutics Ord.
- Started 24 new stock positions in Ipath Dow Jones-aig Commodity, Intelsat Sa, Karuna Therapeutics Ord, BND, GWL, Intra Cellular Therapies, VB, Sundial Growers Inc, Vanguard S&p 500 Etf idx fd, GMM. Beyond Meat Inc, Mortgage Reit Index real, Direxion Shs Etf Tr call, Ishares Tr Global Reit Etf, Zoom Video Communications In cl a, Tilray Inc, VO, XLNX, SPY, Sage Therapeutics, Innovative Industria A, Spdr Series Trust cmn, Sarepta Therapeutics, Cronos Group Inc.
- Reduced shares in these 10 stocks: Schwab Strategic Tr cmn (-$86.95M), SCHB (-$12.46M), SCHG (-$5.93M), Roku Inc, Schwab Strategic Tr us lrg cap etf, Dbx Etf Tr deutsche usd etf, SCHA, Crowdstrike Hldgs Inc cl a, , SCHE.
- Sold out of its positions in HYT, Dbx Etf Tr deutsche usd etf, TNA, BGU, Direxion Shs Etf Tr sp biotch bl, Gw Pharmaceuticals Plc ads, ISI, IJH, Ishares Core Msci Eafe Etf core msci eafe, Ishares Inc core msci emkt. XES, SCHG, Schwab Strategic Tr cmn, Twilio Inc cl a.
- Gainplan was a net buyer of stock by $13.97M.
- Gainplan has $189.96M in assets under management (AUM), growing by 11.52%.
Companies in the Gainplan portfolio as of December 2019 quarter
Past 13F-HR SEC Filings by Gainplan
- Gainplan 2019 Q3 filed Nov. 5, 2019
- Gainplan 2019 Q2 filed Aug. 7, 2019
- Gainplan 2019 Q1 filed May 13, 2019
- Gainplan 2018 Q4 filed Feb. 8, 2019
- Gainplan 2018 Q3 filed Nov. 14, 2018
- Gainplan 2018 Q2 filed Aug. 8, 2018
- Gainplan 2018 Q1 filed May 11, 2018
- Gainplan 2017 Q4 filed Feb. 8, 2018
- Gainplan 2017 Q3 filed Nov. 6, 2017
- Gainplan 2017 Q2 filed Aug. 2, 2017
- Gainplan 2016 Q4 filed Feb. 13, 2017